AIMS: To evaluate in detail the extent to which step sectioning and immunohistochemical examination of sentinel lymph nodes (SLNs) in patients with melanoma reveal additional node positive patients, to arrive at a sensitive yet workable protocol for histopathological SLN examination. METHODS: The study comprised 29 patients with one or more positive SLN after a successful SLN procedure for clinical stage I/II melanoma. SLNs were lamellated into pieces of approximately 0.5 cm in size. One initial haematoxylin and eosin (H&E) stained central cross section was made for each block. When negative, four step ribbons were cut at intervals of 250 microm. One section from each ribbon was stained with H&E, and one was used for immunohistochemistry (IHC). RESULTS: When taking the cumulative total of detected metastases at level 5 as 100%, the percentage of SLN positive patients increased from 79%, 83%, 83%, 90% to 93% in the H&E sections through levels 1-5, and with IHC these values were 83%, 86%, 90%, 97%, and 100%, respectively. One of six patients in whom metastases were detected at levels 2-5 only had metastases in the subsequent additional lymph node dissection. CONCLUSIONS: Multiple level sectioning of SLNs (five levels at 250 microm intervals) and the use of IHC detects additional metastases up to the last level in melanoma SLNs. Although more levels of sectioning might increase the yield even further, this protocol ensures a reasonable workload for the pathologist with an acceptable sensitivity when compared with the published literature.
AIMS: To evaluate in detail the extent to which step sectioning and immunohistochemical examination of sentinel lymph nodes (SLNs) in patients with melanoma reveal additional node positive patients, to arrive at a sensitive yet workable protocol for histopathological SLN examination. METHODS: The study comprised 29 patients with one or more positive SLN after a successful SLN procedure for clinical stage I/II melanoma. SLNs were lamellated into pieces of approximately 0.5 cm in size. One initial haematoxylin and eosin (H&E) stained central cross section was made for each block. When negative, four step ribbons were cut at intervals of 250 microm. One section from each ribbon was stained with H&E, and one was used for immunohistochemistry (IHC). RESULTS: When taking the cumulative total of detected metastases at level 5 as 100%, the percentage of SLN positive patients increased from 79%, 83%, 83%, 90% to 93% in the H&E sections through levels 1-5, and with IHC these values were 83%, 86%, 90%, 97%, and 100%, respectively. One of six patients in whom metastases were detected at levels 2-5 only had metastases in the subsequent additional lymph node dissection. CONCLUSIONS: Multiple level sectioning of SLNs (five levels at 250 microm intervals) and the use of IHC detects additional metastases up to the last level in melanoma SLNs. Although more levels of sectioning might increase the yield even further, this protocol ensures a reasonable workload for the pathologist with an acceptable sensitivity when compared with the published literature.
Authors: J F Thompson; W H McCarthy; C M Bosch; C J O'Brien; M J Quinn; S Paramaesvaran; K Crotty; S W McCarthy; R F Uren; R Howman-Giles Journal: Melanoma Res Date: 1995-08 Impact factor: 3.599
Authors: J E Gershenwald; W Thompson; P F Mansfield; J E Lee; M I Colome; C H Tseng; J J Lee; C M Balch; D S Reintgen; M I Ross Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544
Authors: Martin G Cook; Margaret A Green; Brian Anderson; Alexander M M Eggermont; Dirk J Ruiter; Alain Spatz; Mark W Kissin; Barry W E M Powell Journal: J Pathol Date: 2003-07 Impact factor: 7.996
Authors: D Reintgen; C W Cruse; K Wells; C Berman; N Fenske; F Glass; K Schroer; R Heller; M Ross; G Lyman Journal: Ann Surg Date: 1994-12 Impact factor: 12.969
Authors: Barbara G Molenkamp; Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Wim Vos; Pepijn G J T B Wijnands; Rik J Scheper; Tanja D de Gruijl Journal: Am J Pathol Date: 2005-11 Impact factor: 4.307
Authors: Magdalena Kowalewska; Jakub Radziszewski; Krzysztof Goryca; Mateusz Bujko; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Janusz Aleksander Siedlecki; Mariusz Bidzinski Journal: BMC Cancer Date: 2012-06-06 Impact factor: 4.430
Authors: Mike Visser; Mehdi Jiwa; Anja Horstman; Antoinette A T P Brink; Rene P Pol; Paul van Diest; Peter J F Snijders; Chris J L M Meijer Journal: Int J Cancer Date: 2008-06-01 Impact factor: 7.396